Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1991 May;35(5):961–966. doi: 10.1128/aac.35.5.961

Synergistic effects between amoxicillin, metronidazole, and the hydroxymetabolite of metronidazole against Actinobacillus actinomycetemcomitans.

M J Pavicić 1, A J van Winkelhoff 1, J de Graaff 1
PMCID: PMC245136  PMID: 1854177

Abstract

Interactions between metronidazole and amoxicillin, metronidazole and its hydroxymetabolite, and amoxicillin and the hydroxymetabolite of metronidazole were investigated with checkerboard titrations in combination with accurately determined MICs and MBCs. Actinobacillus actinomycetemcomitans was used as the test organism. Synergism was found for all three combinations. Fractional inhibitory concentration indices and fractional bactericidal concentration indices varied from 0.3 to 0.7. These synergistic interactions between these antibiotics may explain the efficacy of the combination of metronidazole and amoxicillin in various bacterial infections, including periodontal disease.

Full text

PDF
961

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Axon A. T. Campylobacter pylori--therapy review. Scand J Gastroenterol Suppl. 1989;160:35–38. doi: 10.3109/00365528909091733. [DOI] [PubMed] [Google Scholar]
  2. Berenbaum M. C. A method for testing for synergy with any number of agents. J Infect Dis. 1978 Feb;137(2):122–130. doi: 10.1093/infdis/137.2.122. [DOI] [PubMed] [Google Scholar]
  3. Brogeden R. N., Speight T. M., Avery G. S. Amoxycillin: A review of its antibacterial and pharmacokinietic properties and therapeutic use. Drugs. 1975;9(2):88–140. doi: 10.2165/00003495-197509020-00002. [DOI] [PubMed] [Google Scholar]
  4. Cirau-Vigneron N., Barrier J., Becue J., Chartier M., Giraud J. R., Landes P., Leng J., Raudrant D., Reme J. M. Amoxycillin/clavulanic acid ('Augmentin') compared with a combination of aminopenicillin, aminoglycoside and metronidazole in the treatment of pelvic inflammatory disease. Pharmatherapeutica. 1989;5(5):312–319. [PubMed] [Google Scholar]
  5. Eykyn S. J. The therapeutic use of metronidazole in anaerobic infection: six years' experience in a London hospital. Surgery. 1983 Jan;93(1 Pt 2):209–214. [PubMed] [Google Scholar]
  6. Gaudin G. Etude clinique comparative entre la Rocéphine (Roche) et la doxycycline, l'amoxycilline, l'érythromycine et l'association amoxycilline + métronidazole en gynécologie. Gynakol Rundsch. 1985;25(2):86–95. [PubMed] [Google Scholar]
  7. Goené R. J., Winkel E. G., Abbas F., Rodenburg J. P., van Winkelhoff A. J., de Graaff J. Microbiology in diagnosis and treatment of severe periodontitis. A report of four cases. J Periodontol. 1990 Jan;61(1):61–64. doi: 10.1902/jop.1990.61.1.61. [DOI] [PubMed] [Google Scholar]
  8. Gulaid A., Houghton G. W., Lewellen O. R., Smith J., Thorne P. S. Determination of metronidazole and its two major metabolites in biological fluids by high pressure liquid chromatography. Br J Clin Pharmacol. 1978 Nov;6(5):430–432. doi: 10.1111/j.1365-2125.1978.tb04608.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Horrevorts A. M., de Ridder C. M., Poot M. C., de Jonge M. J., Degener J. E., Dzoljic-Danilovic G., Michel M. F., Kerrebijn K. F. Chequerboard titrations: the influence of the composition of serial dilutions of antibiotics on the fractional inhibitory concentration index and fractional bactericidal concentration index. J Antimicrob Chemother. 1987 Jan;19(1):119–125. doi: 10.1093/jac/19.1.119. [DOI] [PubMed] [Google Scholar]
  10. Höffler U., Niederau W., Pulverer G. Susceptibility of Bacterium actinomycetem comitans to 45 antibiotics. Antimicrob Agents Chemother. 1980 Jun;17(6):943–946. doi: 10.1128/aac.17.6.943. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Jousimies-Somer H., Asikainen S., Suomala P., Summanen P. Activity of metronidazole and its hydroxy metabolite against clinical isolates of Actinobacillus actinomycetemcomitans. Oral Microbiol Immunol. 1988 Mar;3(1):32–34. doi: 10.1111/j.1399-302x.1988.tb00602.x. [DOI] [PubMed] [Google Scholar]
  12. Mandell R. L., Socransky S. S. Microbiological and clinical effects of surgery plus doxycycline on juvenile periodontitis. J Periodontol. 1988 Jun;59(6):373–379. doi: 10.1902/jop.1988.59.6.373. [DOI] [PubMed] [Google Scholar]
  13. Mouton C., Dextraze L., Mayrand D. Sensibilité au métronidazole, à la spiramycine et à leur association de bactéries à potentiel parodontopathique. J Biol Buccale. 1984 Mar;12(1):17–26. [PubMed] [Google Scholar]
  14. Renvert S., Wikström M., Dahlén G., Slots J., Egelberg J. Effect of root debridement on the elimination of Actinobacillus actinomycetemcomitans and Bacteroides gingivalis from periodontal pockets. J Clin Periodontol. 1990 Jul;17(6):345–350. doi: 10.1111/j.1600-051x.1990.tb00029.x. [DOI] [PubMed] [Google Scholar]
  15. Renvert S., Wikström M., Dahlén G., Slots J., Egelberg J. On the inability of root debridement and periodontal surgery to eliminate Actinobacillus actinomycetemcomitans from periodontal pockets. J Clin Periodontol. 1990 Jul;17(6):351–355. doi: 10.1111/j.1600-051x.1990.tb00030.x. [DOI] [PubMed] [Google Scholar]
  16. Rodenburg J. P., van Winkelhoff A. J., Winkel E. G., Goené R. J., Abbas F., de Graff J. Occurrence of Bacteroides gingivalis, Bacteroides intermedius and Actinobacillus actinomycetemcomitans in severe periodontitis in relation to age and treatment history. J Clin Periodontol. 1990 Jul;17(6):392–399. doi: 10.1111/j.1600-051x.1990.tb00036.x. [DOI] [PubMed] [Google Scholar]
  17. Rosling B. G., Slots J., Webber R. L., Christersson L. A., Genco R. J. Microbiological and clinical effects of topical subgingival antimicrobial treatment on human periodontal disease. J Clin Periodontol. 1983 Sep;10(5):487–514. doi: 10.1111/j.1600-051x.1983.tb02180.x. [DOI] [PubMed] [Google Scholar]
  18. Slots J., Bragd L., Wikström M., Dahlén G. The occurrence of Actinobacillus actinomycetemcomitans, Bacteroides gingivalis and Bacteroides intermedius in destructive periodontal disease in adults. J Clin Periodontol. 1986 Jul;13(6):570–577. doi: 10.1111/j.1600-051x.1986.tb00849.x. [DOI] [PubMed] [Google Scholar]
  19. Slots J., Evans R. T., Lobbins P. M., Genco R. J. In vitro antimicrobial susceptibility of Actinobacillus actinomycetemcomitans. Antimicrob Agents Chemother. 1980 Jul;18(1):9–12. doi: 10.1128/aac.18.1.9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Slots J., Genco R. J. Black-pigmented Bacteroides species, Capnocytophaga species, and Actinobacillus actinomycetemcomitans in human periodontal disease: virulence factors in colonization, survival, and tissue destruction. J Dent Res. 1984 Mar;63(3):412–421. doi: 10.1177/00220345840630031101. [DOI] [PubMed] [Google Scholar]
  21. Slots J., Rams T. E. Antibiotics in periodontal therapy: advantages and disadvantages. J Clin Periodontol. 1990 Aug;17(7 ):479–493. doi: 10.1111/j.1365-2710.1992.tb01220.x. [DOI] [PubMed] [Google Scholar]
  22. Slots J., Rosling B. G. Suppression of the periodontopathic microflora in localized juvenile periodontitis by systemic tetracycline. J Clin Periodontol. 1983 Sep;10(5):465–486. doi: 10.1111/j.1600-051x.1983.tb02179.x. [DOI] [PubMed] [Google Scholar]
  23. Slots J. Selective medium for isolation of Actinobacillus actinomycetemcomitans. J Clin Microbiol. 1982 Apr;15(4):606–609. doi: 10.1128/jcm.15.4.606-609.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Van Oosten M. A., Notten F. J., Mikx F. H. Metronidazole concentrations in human plasma, saliva, and gingival crevice fluid after a single dose. J Dent Res. 1986 Dec;65(12):1420–1423. doi: 10.1177/00220345860650120801. [DOI] [PubMed] [Google Scholar]
  25. Walker C. B., Pappas J. D., Tyler K. Z., Cohen S., Gordon J. M. Antibiotic susceptibilities of periodontal bacteria. In vitro susceptibilities to eight antimicrobial agents. J Periodontol. 1985 Nov;56(11 Suppl):67–74. doi: 10.1902/jop.1985.56.11s.67. [DOI] [PubMed] [Google Scholar]
  26. van Winkelhoff A. J., Rodenburg J. P., Goené R. J., Abbas F., Winkel E. G., de Graaff J. Metronidazole plus amoxycillin in the treatment of Actinobacillus actinomycetemcomitans associated periodontitis. J Clin Periodontol. 1989 Feb;16(2):128–131. doi: 10.1111/j.1600-051x.1989.tb01626.x. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES